Literature DB >> 6601312

Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.

M S Pollack, B Safai, P L Myskowski, J W Gold, J Pandey, B Dupont.   

Abstract

An outbreak of Kaposi's sarcoma in homosexual men has recently been observed in New York and California which differs from the "classic" North American disease with regard to younger age of onset and clinical prognosis. Although the exact mechanism for initiation of either disease is still unknown, a viral mechanism has been suggested in both cases. In order to investigate the possible role of HLA-associated variations in genetic susceptibility, 39 patients with histologically documented Kaposi's sarcoma were typed for HLA-A,B,C antigens. Most of these patients were also typed for HLA-DR antigens and for Gm allotypes. A significant increase in DR5 occurred in both groups. Decreases in B8 and DR3 and an increase in homozygosity for the Gm haplotype 3;5,13 were also noted. These results suggest that HLA and Gm linked immune response factors may play a role in the induction of both these forms of the disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601312     DOI: 10.1111/j.1399-0039.1983.tb00364.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

1.  A study of the HLA-D region in patients with classic Kaposi's sarcoma.

Authors:  E Robbins; N Cohen; L Contu; J Dausset
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

3.  The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors:  K Balassa; H Andrikovics; P Remenyi; A Batai; A Bors; K P Kiss; A Szilvasi; K Rajczy; D Inotai; L Gopcsa; L Lengyel; A Barta; M Reti; A Tordai; T Masszi
Journal:  Bone Marrow Transplant       Date:  2015-07-06       Impact factor: 5.483

Review 4.  The acquired immune deficiency syndrome.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

5.  HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis.

Authors:  C Kratzik; P Aiginger; R Kuzmits; J Spona; M Kirnbauer; A Seiser; W R Mayr
Journal:  Urol Res       Date:  1989

6.  No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients.

Authors:  L Strichman-Almashanu; S Weltfriend; O Gideoni; R Friedman-Birnbaum; S Pollack
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

7.  Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.

Authors:  Evgeny Arons; Sharon Adams; David J Venzon; Ira Pastan; Robert J Kreitman
Journal:  Br J Haematol       Date:  2014-06-13       Impact factor: 6.998

8.  Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression.

Authors:  S Itescu; S Rose; E Dwyer; R Winchester
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

9.  HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma.

Authors:  H E Prince; R W Schroff; G Ayoub; S Han; M S Gottlieb; J L Fahey
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

Review 10.  Kaposi's sarcoma.

Authors:  A G Dalgleish
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.